Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Pancreatic cancer screening.

Shin EJ, Canto MI.

Gastroenterol Clin North Am. 2012 Mar;41(1):143-57. doi: 10.1016/j.gtc.2011.12.001. Epub 2012 Jan 5. Review.

2.

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Langer P, Kann PH, Fendrich V, Habbe N, Schneider M, Sina M, Slater EP, Heverhagen JT, Gress TM, Rothmund M, Bartsch DK.

Gut. 2009 Oct;58(10):1410-8. doi: 10.1136/gut.2008.171611. Epub 2009 May 25.

PMID:
19470496
3.

Variation in precursor lesions of pancreatic cancer among high-risk groups.

Potjer TP, Schot I, Langer P, Heverhagen JT, Wasser MN, Slater EP, Klöppel G, Morreau HM, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bargello M, Gress TM, Vasen HF, Bartsch DK; Leiden Familial Pancreatic Cancer Group.; FaPaCa registry..

Clin Cancer Res. 2013 Jan 15;19(2):442-9. doi: 10.1158/1078-0432.CCR-12-2730. Epub 2012 Nov 21.

4.

Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study.

Zubarik R, Gordon SR, Lidofsky SD, Anderson SR, Pipas JM, Badger G, Ganguly E, Vecchio J.

Gastrointest Endosc. 2011 Jul;74(1):87-95. doi: 10.1016/j.gie.2011.03.1235.

PMID:
21704809
5.

Familial pancreatic cancer--status quo.

Fendrich V, Langer P, Bartsch DK.

Int J Colorectal Dis. 2014 Feb;29(2):139-45. doi: 10.1007/s00384-013-1760-3. Epub 2013 Aug 16. Review.

PMID:
23948969
6.

New strategies for the early detection of pancreatic cancer.

Petrone MC, Arcidiacono PG.

Expert Rev Gastroenterol Hepatol. 2016;10(2):157-9. doi: 10.1586/17474124.2016.1122521. Epub 2015 Dec 14. Review.

PMID:
26582179
7.

Strategies for screening for pancreatic adenocarcinoma in high-risk patients.

Canto MI.

Semin Oncol. 2007 Aug;34(4):295-302. Review.

PMID:
17674957
8.

The actual management of early pancreatic cancer.

Iglesias García J, Lariño-Noia J, Domínguez-Muñoz JE.

Minerva Gastroenterol Dietol. 2012 Dec;58(4):321-30. Review.

PMID:
23207609
9.

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN.

Clin Gastroenterol Hepatol. 2006 Jun;4(6):766-81; quiz 665. Epub 2006 May 6.

PMID:
16682259
10.

Early diagnosis of pancreatic cancer, time to screen high-risk individuals?

Iglesias-Garcia J, Lariño-Noia J, Dominguez-Muñoz JE.

Minerva Gastroenterol Dietol. 2011 Jun;57(2):205-12.

PMID:
21587149
11.

Multiple small "imaging" branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?

Bartsch DK, Dietzel K, Bargello M, Matthaei E, Kloeppel G, Esposito I, Heverhagen JT, Gress TM, Slater EP, Langer P.

Fam Cancer. 2013 Mar;12(1):89-96. doi: 10.1007/s10689-012-9582-y.

PMID:
23179793
12.

Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer.

Harinck F, Poley JW, Kluijt I, Fockens P, Bruno MJ; Dutch Research Group of Pancreatic Cancer Surveillance in High-Risk Individuals..

Dig Dis. 2010;28(4-5):670-8. doi: 10.1159/000320095. Epub 2010 Nov 18.

PMID:
21088419
13.

Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?

Haugk B.

Histopathology. 2010 Oct;57(4):503-14. doi: 10.1111/j.1365-2559.2010.03610.x. Epub 2010 Sep 28. Review.

PMID:
20875068
14.

Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers.

Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthäi E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, Bonsing BA, de Vos Tot Nederveen Cappel WH, Bergman W, Wasser M, Morreau H, Klöppel G, Schicker C, Steinkamp M, Figiel J, Esposito I, Mocci E, Vazquez-Sequeiros E, Sanjuanbenito A, Muñoz-Beltran M, Montans J, Langer P, Fendrich V, Bartsch DK.

J Clin Oncol. 2016 Jun 10;34(17):2010-9. doi: 10.1200/JCO.2015.64.0730. Epub 2016 Apr 25.

PMID:
27114589
15.

Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.

Larghi A, Verna EC, Lecca PG, Costamagna G.

Clin Cancer Res. 2009 Mar 15;15(6):1907-14. doi: 10.1158/1078-0432.CCR-08-1966. Epub 2009 Mar 10. Review.

16.

Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.

Mastoraki A, Chatzimavridou-Grigoriadou V, Chatzipetrou V, Mastoraki S, Papanikolaou IS, Danias N, Smyrniotis V, Arkadopoulos N.

J Gastrointest Cancer. 2014 Sep;45(3):256-61. doi: 10.1007/s12029-014-9609-8. Review.

PMID:
24756831
17.

Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.

Morgan TK, Hardiman K, Corless CL, White SL, Bonnah R, Van de Vrugt H, Sheppard BC, Grompe M, Cosar EF, Streeter PR.

Cancer Cytopathol. 2013 Jan;121(1):37-46. doi: 10.1002/cncy.21223. Epub 2012 Jul 18.

18.

Screening for pancreatic cancer: why, how, and who?

Poruk KE, Firpo MA, Adler DG, Mulvihill SJ.

Ann Surg. 2013 Jan;257(1):17-26. doi: 10.1097/SLA.0b013e31825ffbfb. Review.

19.

PanGen-Fam: Spanish registry of hereditary pancreatic cancer.

Mocci E, Guillen-Ponce C, Earl J, Marquez M, Solera J, Salazar-López MT, Calcedo-Arnáiz C, Vázquez-Sequeiros E, Montans J, Muñoz-Beltrán M, Vicente-Bártulos A, González-Gordaliza C, Sanjuanbenito A, Guerrero C, Mendía E, Lisa E, Lobo E, Martínez JC, Real FX, Malats N, Carrato A.

Eur J Cancer. 2015 Sep;51(14):1911-7. doi: 10.1016/j.ejca.2015.07.004. Epub 2015 Jul 23.

PMID:
26212471
20.

Management strategies for patients with hereditary pancreatic cancer.

Brentnall TA.

Curr Treat Options Oncol. 2005 Sep;6(5):437-45. Review.

PMID:
16107246

Supplemental Content

Support Center